Loading company…
Nanjing Orui researches and develops anti-tumor and antiviral drugs.
Nanjing Orui Pharmaceutical focuses on research and development of anti-tumor and antiviral drugs. It has a tissue-specific E3 ligase platform, an in vitro screening platform for coronavirus drugs, and 6 new drug R&D pipelines. Founded in 2021, the company is based in Nanjing, China.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in